Stock Fundamentals

Company Information

Company Name
Vericel Corp Ord
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN: US92346J1088
CIK: 0000887359
CUSIP: 00253U107
Currency: USD
Full Time Employees: 398
Phone: 617 588 5555
Fiscal Year End: December
IPO Date: Feb 04, 1997
Description:

Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies and specialty biologic products for sports medicine and severe burn care markets in North America. The company markets autologous cell therapy products comprising MACI, an autologous cultured chondrocytes on porcine collagen membrane for the repair of symptomatic, and single or multiple full-thickness cartilage defects of the knee; Epicel, a permanent skin replacement humanitarian use device for the treatment of adult and pediatric patients with deep-dermal or full-thickness burns; and NexoBrid, a biological orphan product for eschar removal in adults and pediatric patients with deep partial-thickness and/or full-thickness thermal burns. Vericel Corporation was formerly known as Aastrom Biosciences, Inc. and changed its name to Vericel Corporation in November 2014. The company was incorporated in 1989 and is headquartered in Burlington, Massachusetts.

Address:

25 Blue Sky Drive, Burlington, MA, United States, 01803

Directors & Officers

Name Title Year Born
Mr. Dominick C. Colangelo Esq. CEO, President & Director 1964
Mr. Joseph Anthony Mara Jr. CFO & Treasurer 1976
Mr. Michael Halpin Chief Operating Officer 1962
Mr. Sean C. Flynn Chief Legal Officer 1974
Dr. Jonathan M. Hopper FRCSEd., M.B. Ch.B. Chief Medical Officer 1962
Mr. Jonathan D. Siegal Principal Accounting Officer, VP & Corporate Controller NA
Mr. Eric Burns Vice President of Finance & Investor Relations NA
Mr. Roland DeAngelis Chief Marketing Officer NA
Mr. Patrick J. Fowler Senior Vice President of Corporate Development & Strategy NA
Mr. Mike Gilligan Senior Vice President of Sales NA

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Apr 02, 2026 Jonathan Mark Hopper N/A Sale 3.47K $35.00 $121.52K

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
BlackRock Inc 7.77M Mar 31, 2026 15.21% $0.00 0.76%
Vanguard Group Inc 3.58M Dec 31, 2025 7.02% $0.00 1.94%
State Street Corp 3.15M Mar 31, 2026 6.17% $0.00 -0.37%
Soleus Capital Management, L.P. 2.55M Mar 31, 2026 4.99% $3.32 233.65%
Conestoga Capital Advisors, LLC 2.46M Mar 31, 2026 4.82% $1.58 9.26%
Vanguard Capital Management, LLC 2.23M Mar 31, 2026 4.37% $0.00 0.00%
William Blair Investment Management, LLC 1.83M Mar 31, 2026 3.59% $0.19 -17.52%
BNP Paribas Investment Partners SA 1.72M Mar 31, 2026 3.38% $0.06 9.21%
Geneva Capital Management 1.65M Mar 31, 2026 3.22% $1.13 -9.85%
GW&K Investment Management, LLC 1.62M Mar 31, 2026 3.17% $0.46 2.27%
Congress Asset Management Company, LLP 1.51M Mar 31, 2026 2.95% $0.35 -9.47%
Geode Capital Management, LLC 1.25M Mar 31, 2026 2.46% $0.00 2.67%
SG Capital Management, LLC 1.21M Mar 31, 2026 2.37% $2.58 0.00%
Bank of America Corp 1.10M Mar 31, 2026 2.15% $0.00 19.69%
Vanguard Portfolio Management, LLC 991.63K Mar 31, 2026 1.94% $0.00 0.00%
Loomis, Sayles & Company LP 975.45K Mar 31, 2026 1.91% $0.04 -7.69%
Silvercrest Asset Management Group LLC 959.21K Mar 31, 2026 1.88% $0.22 41.09%
Royal Bank of Canada 882.16K Mar 31, 2026 1.73% $0.01 -11.35%
Dimensional Fund Advisors, Inc. 844.76K Mar 31, 2026 1.65% $0.01 3.57%
Champlain Investment Partners, LLC 815.17K Mar 31, 2026 1.60% $0.33 -20.77%

Shares Statistics

Shares Outstanding: 51.07M
Shares Float: 50.44M
% Insiders: 119.40%
% Institutions: 11,369.30%
Short % Float: 12.40%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 iShares Core S&P Small-Cap ETF 3.07M 6.01% ▲ 0.04% May 29, 2026
2 Vanguard Total Stock Mkt Idx Inv 1.62M 3.17% ▲ 0.40% Apr 30, 2026
3 Conestoga Small Cap Investors 1.41M 2.76% ▼ 9.32% Apr 30, 2026
4 State Street® SPDR® S&P® Biotech ETF 1.24M 2.42% ▼ 0.61% May 31, 2026
5 iShares Russell 2000 ETF 1.20M 2.34% ▲ 0.93% May 29, 2026
6 BNP Paribas US Small Cap ClassicC 828.03K 1.62% ▲ 0.03% Apr 30, 2026
7 Champlain Small Company Fund, LLC 781.84K 1.53% ▼ 4.14% May 31, 2026
8 Conestoga Small Cap Growth 719.84K 1.41% ▲ 15.81% Mar 31, 2026
9 Congress Small Cap Growth Institutional 700.00K 1.37% ▲ 9.34% Apr 30, 2026
10 BNP Paribas Health Cr Innovtr Cl Cap 681.09K 1.33% ▼ 12.60% Apr 30, 2026

Valuation Metrics

Enterprise Value: $2.35B
Trailing P/E: 109.30
Forward P/E: 99.01

Financial Highlights

Market Cap: $2.40B
EBITDA: $27.90M
P/E Ratio: $109.30
PEG Ratio: $0.00
Book Value: $6.98
Earnings/Share: $0.43
Profit Margin: 7.35%
Operating Margin: -11.79%
ROA (TTM): 2.17%
ROE (TTM): 6.59%
Revenue (TTM): $292.09M
Revenue/Share (TTM): $5.78
Earnings Growth (YOY): 18.90%
Revenue Growth (YOY): 30.10%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

Financial Ratios

Balance Sheet (Yearly)

Financial Ratios

Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2025-12-31 5.03x 0.04x 0.27x 7.10x 0.46x
2024-12-31 4.23x 0.03x 0.33x 7.36x 0.56x
2023-12-31 4.49x 0.03x 0.36x -10.77x 2.16x
2022-12-31 4.99x 0.02x 0.30x -46.61x -0.37x
2021-12-31 6.08x 0.02x 0.30x -1,963.50x -0.65x
2020-12-31 5.50x 0.03x 0.35x 395.33x 0.82x
2019-12-31 5.64x 0.05x 0.28x -1,406.38x -0.70x
2018-12-31 7.62x 0.00x 0.14x -2.26x 0.00x
2017-12-31 3.86x 0.76x 0.59x -13.54x -1.18x
2016-12-31 3.48x 0.03x 0.49x -61.29x -0.05x
2015-12-31 2.26x 0.01x 0.35x -1,852.33x -0.01x
2014-12-31 3.51x 0.01x 0.25x -3,922.33x -0.01x
2013-12-31 1.59x 0.00x 0.58x -1,905.82x 0.00x
2012-12-31 2.47x 0.00x 0.37x -2,813.33x 0.00x
2011-12-31 0.30x -0.01x 2.68x -2,904.00x 0.00x
2010-12-31 1.06x 0.07x 0.91x -445.10x -0.01x
2009-12-31 10.55x 0.03x 0.10x -221.49x -0.03x
2008-12-31 11.46x 0.03x 0.11x -290.67x -0.05x
2007-12-31 8.62x 0.04x 0.14x -231.77x -0.06x
2006-12-31 17.20x 0.04x 0.06x N/A -0.08x
2005-12-31 38.14x 0.00x 0.03x N/A 0.00x
2004-12-31 31.96x 0.00x 0.03x N/A 0.00x
2003-12-31 20.44x 0.00x 0.05x N/A 0.00x
2002-12-31 15.13x 0.00x 0.06x N/A 0.00x
2001-12-31 11.60x 0.00x 0.08x N/A 0.00x
2000-12-31 13.12x 0.00x 0.07x N/A 0.00x
1999-12-31 8.78x 0.00x 0.11x N/A 0.00x
1998-12-31 7.62x 0.01x 0.12x N/A -0.01x
1997-12-31 9.71x 0.01x 0.10x N/A -0.01x
1996-12-31 9.67x 0.01x 0.10x N/A -0.01x
1995-12-31 4.08x 0.02x 0.21x N/A -0.01x

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about VCEL.US!